期刊文献+

用改进的理论溶剂化方程预测药物的经皮渗透性 被引量:2

Prediction of percutaneous drug permeability using modified theoretical linear solvation energy relationship
下载PDF
导出
摘要 目的 :预测药物经过人体表皮的渗透系数。方法 :用半经验自洽场分子轨道 AM1法计算量子化学参数 ,用改进的理论溶剂化方程模型建立药物透过人体表皮的渗透系数的回归方程式。结果 :36个非电解质化合物透过人体表皮的渗透系数 (P)和分子体积 (V)、氢键酸度 (Σα2 H)、氢键碱度 (Σβ2 H)和极化率指数 (πI)等理论参数之间具有良好的线性相关性 ,回归方程式为 :log P=- 6 .790 +1.5 71V+0 .15 5 0 πI- 1.2 95 Σα2 H - 2 .4 85 Σβ2 H (n=36 ,r=0 .9777)。结论 :可以用改进的理论溶剂化方程预测药物的经皮渗透性。 Objective: To predict the percutaneous drug permeability coefficients with modified regression equation.Methods:The semiempirical self-consistent field molecular orbital calculation AM1 method was used to calculate the quantum chemical parameters and the modified theoretical linear solvation energy relationship was used to obtain the regression equation of the permeability coefficients of drugs through human epidermis.Results:The permeability coefficients (P) of 36 nonelectrolytes were well linearly correlated with their theoretical descriptors including molecular volume (V),hydrogen-bond acidity (Σα 2H),hydrogen-bond basicity (Σβ 2H) and polarizability index (π I).The regression equation was logP=-6.790+1.571 V+0.1550 π I-1.295Σα 2H-2.485Σβ 2H(n=36,r=0.9777).Conclusion:The modified theoretical linear solvation energy relationship can be used to predict the skin permeability of drugs.
出处 《浙江大学学报(医学版)》 CAS CSCD 2003年第4期352-355,共4页 Journal of Zhejiang University(Medical Sciences)
关键词 药物设计 经皮吸收 渗透系数 氢键 AML Drug design Percutaneous absorption Permeability coefficient Hydrogen bond AM1
  • 相关文献

参考文献4

二级参考文献17

  • 1[1]Tayar N E, Tsti R S, Testa B, et al. J. Pharm Sci., 1991, 80:744
  • 2[2]Kamlet M J, Taft R W. J. Am. Chem. Soc., 1976, 98:377
  • 3[3]Kamlet M J, Taft R W. J. Am. Chem Soc., 1976, 98:2886
  • 4[4]Abraham M H, Martins F, Mitchell R C. J. Pharm. Pharmacol., 1997, 49:858
  • 5[5]Dewar M J S, Zoebisch E G, Healy E F, et al. J. Am Chem Soc, 1985, 107:3902
  • 6[6]Abraham M H. J. Phys. Org. Chem., 1993, 6:660
  • 7梁文权,药学学报,1992年,27卷,684页
  • 8梁栋,中国医学科学院学报,1990年,12卷,262页
  • 9朱本仁,蒙特卡罗方法引论,1987年
  • 10Fu X C,中国药学杂志,2000年,35卷,4期,276页

共引文献28

同被引文献15

  • 1傅旭春,孙群.β受体阻断剂的小肠吸收速率与分子结构的相关性[J].浙江大学学报(医学版),2005,34(2):177-180. 被引量:3
  • 2任鲁华,李强,吕育齐.增加难溶性药物溶解度方法新进展[J].黑龙江医药,2007,20(1):25-27. 被引量:15
  • 3YEE S.In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small instinal) absorption in man-fact or myth[J].Pharm Res,1997,14(6):763-766.
  • 4LIPINSKI C A,LOMBARDO F,DOMINY B W,et al.Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J].Adv Drug Deliv Rev,1997,23(1-3):3-25.
  • 5PALM K,STENBERG P,LUTHMAN K,et al.Polar molecular surface properties predict the intestinal absorption of drugs in humans[J].Pharm Res,1997,14(5):568-571.
  • 6CLARK D E.Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena.1.Prediction of intestinal absorption[J].J Pharm Sci,1999,88(8):807-814.
  • 7ZHAO Y H,ABRAHAM M H,HERSEY A,et al.Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors[J].J Pharm Sci,2001,90(6):749-784.
  • 8PALM K,LUTHMAN K,UNGELL A L,et al.Evalauation of dynamic polar molecular surface area as predictor of drug absorption:comparison with other computational and experimental predictors[J].J Med Chem,1998,41(27):5 382-5 392.
  • 9LOBLEY R W,BURROWS P C,WARWICK R,et al.Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose,lactose and L-arabinose.Clin Sci,1990,79(2):175-183.
  • 10商志才,俞庆森,林瑞森.分子体积及表面积的Monte Carlo模拟计算[J].物理化学学报,1997,13(12):1097-1100. 被引量:16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部